Suzetrigine Frame Trial Comparing Suzetrigine and Acetaminophen
Part of paid clinical trials in Winston-Salem, North Carolina.
- Sponsor
- Wake Forest University Health Sciences
- Study ID
- NCT07525219
- Phase
- PHASE3
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Analgesic Efficacy
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Suzetrigine — DRUG100mg - Medication is self-administered at home on an empty stomach approximately 1-6 hours prior to the procedure.
- acetaminophen — DRUG1000mg - Medication is self-administered at home on an empty stomach approximately 1-6 hours prior to the procedure.
Study Details
Local anesthetic infiltration is a primary source of acute pain during stereotactic procedures.
Key Dates
- Start date
- Jul 31, 2026
- Status verified
- Apr 2026
- Primary completion
- Jul 31, 2027
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Active Comparator: Acetaminophenacetaminophen (1000 mg) - is self-administered at home on an empty stomach approximately 1-6 hours prior to the procedure.
- Experimental: SuzetrigineSuzetrigine (100mg) - is self-administered at home on an empty stomach approximately 1-6 hours prior to the procedure.
Primary Outcome Measure
Visual Analog Scale (VAS-Anxiety) score [ Time Frame: Baseline ]
Central Contacts
- Wendy Jenkins, BSN RN, CCRC336.716.3842
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27157 |
Find similar trials in Winston-Salem, NC
By research site